0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover638.68%IV-77.53%PremiumOct 18, 2024Expiry Date6.90Intrinsic Value100Multiplier12DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9696Delta0.0067Gamma1.25Leverage Ratio-0.0297Theta0.0005Rho1.21Eff Leverage0.0011Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
No comment yet